Physician profile
Anshu Batra
NPI 1356560767
$2,282.96
in general payments reported to CMS, 2019-2025
11 companies · $614 in 2025
The $614 reported for 2025 was more than what 87% of Developmental - Behavioral Pediatrics providers received nationally (typical 2025 total: $79.84).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $482 · 2020: $210 · 2021: $228 · 2022: $85.54 · 2023: $219 · 2024: $445 · 2025: $614.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,277.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,277.43 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Supernus Pharmaceuticals, INC. | $601.97 | 2021-2025 | Qelbree |
| Ironshore Pharmaceuticals INC. | $493.45 | 2019-2024 | Jornay Pm |
| Tris Pharma INC | $426.58 | 2019-2025 | Dyanavel Xr, Onyda Xr |
| Corium, LLC | $208.29 | 2022-2025 | Azstarys |
| Neos Therapeutics, Lp | $163.64 | 2019-2025 | Cotempla Xr-Odt |
| Adlon Therapeutics L.P. | $130.94 | 2020-2021 | |
| Collegium Pharmaceutical, INC. | $126.82 | 2025 | Jornay Pm |
| Takeda Pharmaceuticals U.S.A., INC. | $60.32 | 2020-2021 | |
| Shire North American Group INC | $37.78 | 2019 | |
| Aytu Biopharma, INC. | $24.28 | 2021 | |
| Travere Therapeutics, INC. | $8.89 | 2019-2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Anshu Batra listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.